Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 17, 2024Annals of Clinical and Translational NeurologyOpen Access

Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAnna FrancisEGEmily GibbonsJYJeffrey Yu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Francis et al. (2024) studied this question.

synapsesocial.com/papers/68e64668b6db6435875d76cbhttps://doi.org/10.1002/acn3.52092
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predictive factors for immunosuppression-associated severe and opportunistic infections in AQP4-IgG Neuromyelitis Optica Spectrum Disorder2026
  2. 2Socioeconomic burden of AQP4-antibody seropositive NMOSD: a nationwide registry-based study2024
  3. 3Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder2024
  4. 4A54-03 Paralysis Unveiled: A Case of Neuromyelitis Optica Spectrum Disorder Responding to Rescue Therapy2026
  5. 5Long-Term Outcome of Aquaporin 4-Positive Neuro Myelitis Optica Spectrum Disorder and Efficacy of Long-Term Immunosuppression – A Single-Center Study from South India2026